Ep. 15: Sebastian A. Brunemeier on the LongBio Path to Immortality, Decentralised Science (De-Sci) Business Models to Supercharge Healthcare R&D and the Nexus Between Crypto and Longevity

5 snips

Sep 20, 2022

Sebastian A. Brunemeier, Co-Founder of Healthspan Capital and ImmuneAGE Pharma, shares his insights on the future of human longevity. He discusses groundbreaking advancements in longevity biotech and the urgent need for innovative, decentralized approaches in healthcare. Brunemeier critiques the current regulatory landscape and advocates for new funding models to foster scientific innovation. He also emphasizes the potential of DAOs and blockchain technology to transform research and empower patients, envisioning a future where longevity is accessible and driven by collaborative efforts.

Ask episode

AI Snips

Chapters

Books

Transcript

Episode notes

INSIGHT

Longevity Biotech Revolution

Longevity biotech is a revolution akin to the antibiotics revolution in impact.
Scientific advances show about a third lifespan extension in mice, moving aging from biology to an engineering challenge.

INSIGHT

Understanding Aging's Root Causes

Aging is driven by fundamental molecular damage understood through geroscience.
Addressing root causes, not symptoms, is necessary for broad healthy lifespan extension.

INSIGHT

Decentralized Science Empowers Longevity

Decentralized science (DeSci) restructures research funding and IP on blockchain for transparency.
DAOs enable distributed decision-making and community involvement in funding longevity biotech.

Get the Snipd Podcast app to discover more snips from this episode

Get the app

Niklas speaks with Sebastian A. Brunemeier.

Sebastian is the Co-Founder and General Partner at Healthspan Capital, a venture fund focused on longevity biotech ("LongBio") & geroscience.

He is also the Co-Founder and CEO at ImmuneAGE Pharma, a drug discovery platform for immune system rejuvenation.

He holds an advisor and board member position at multiple companies and organizations, such as VitaDAO and Molecule AG.

This episode is recorded as a primer to the "Prospera Healthtech Summit 2022", a conference taking place September 23-25 on the island of Roatan, Honduras.

Sebastian talks about the scientific breakthroughs of the past decades that show the path to end or at least significantly slow human aging.

What remains is an engineering challenge.

What follows is a wide-ranging conversation about the regulatory, policy, and business challenges when it comes to producing scientific innovations in the field of geroscience to result in drugs and therapies to treat humans.

Sebastian argues that the mainstream legal and financial guardrails of the medical system are broken, and instead we need alternative guardrails built on-chain.

Sebastian and the longevity movement are building these alternative guardrails such as decentralized science (de-sci) funding, decentralized autonomous organizations (DAOs), and intellectual property (IP) on non-fungible tokens (NFTs).

Sounds science-fiction? It is already science-fact. LongBio has attracted close to $5bn in funding in recent years.

Sebastian introduces us to this emerging ecosystem that develops the powers to unleash a new wave of human progress through better health and longer age.

We close the episode by talking about network states, and how Puerto Rico is creating the perfect conditions for a longevity hub.

Niklas on Twitter: https://twitter.com/NiklasAnzinger

Infinita Fund Website: https://infinitafund.com/

Discord: https://discord.gg/Z4H6UjbubK

This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.infinitacitytimes.com